821 studies found for:    "Hepatitis B"
Show Display Options
Rank Status Study
21 Completed Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
22 Completed
Has Results
Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
Condition: Chronic Hepatitis B
Interventions: Drug: FTC/TDF;   Drug: Hepatitis B Immunoglobulin (HBIg)
23 Completed
Has Results
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
24 Active, not recruiting Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Condition: Hepatitis B
Interventions: Biological: Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.;   Biological: EngerixTM-B
25 Completed
Has Results
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
26 Completed
Has Results
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
Condition: Hepatitis b
Interventions: Biological: 60mcg/1.0ml recombinant hepatitis B vaccine;   Biological: 30mcg/1.0ml recombinant hepatitis B vaccine;   Biological: 10mcg/1.0ml recombinant hepatitis B vaccine
27 Unknown  Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load
Condition: Chronic Hepatitis B
Intervention: Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
28 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
29 Completed An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: telbivudine
30 Completed
Has Results
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
Condition: Hepatitis B Vaccine
Intervention: Biological: Engerix™-B Kinder
31 Completed
Has Results
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
Condition: Hepatitis B
Intervention: Procedure: Blood sampling
32 Completed A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Device: medical ozone therapy with humares;   Drug: conventional interferon-α
33 Completed Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Drug: Specific intravenous anti-hepatitis B immunoglobulin
34 Unknown  Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: HBV DNA vaccine;   Other: Placebo
35 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
36 Completed Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
Conditions: Hepatitis B;   HIV Infection
Intervention: Drug: Adefovir
37 Completed Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
Condition: Chronic Hepatitis B
Interventions: Drug: telbivudine;   Drug: tenofovir disproxil fumarate;   Drug: telbivudine plus tenofovir disproxil fumarate
38 Not yet recruiting Entecavir for Biological Agents Associated HBV Reactivation in Rheumatoid Arthritis Patients
Conditions: Rheumatoid Arthritis;   Hepatitis B Reactivation;   Exposure to Hepatitis B Virus
Intervention: Drug: Entecavir
39 Enrolling by invitation TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
Condition: Chronic Hepatitis B
Interventions: Drug: Lamivudine plus adefovir;   Drug: Tenofovir
40 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years